활동 영역

Events and Webinars

DIA 2024 Global Annual Meeting

16-20 June 2024 샌디에고, CA Booth # 1700
Fortrea is proud to participate as *Gold Sponsors* at the upcoming DIA 2024 Global Annual Meeting. Join Fortrea and our invited guest speakers for an engaging panel discussion on Tuesday, June 18th. Stop by booth 1700, grab a snack, and connect with our team of experts. We look forward to meeting with you in San Diego!
Meet the team

Featured presentations

18 Jun | 11:55AM- 12:25PM

Teamwork makes the dream work: How partnering to develop practical solutions that address Site and Patient challenges is changing the clinical trial landscape

Without patients, there are no trials. Without the sites to conduct studies, there are no trials. This simple truth drives inclusivity initiatives, and the surge in technology "solutions". In this panel discussion, we bring together voices from across the clinical trial ecosystem and demonstrate how teamwork comprised of medical expertise, market access insight, patient voice, site advisory boards, and technology partnerships work together with developers & CROs to make teamwork the dream work.

Refreshments and snacks provided

Panel discussion lead by: Amy Hadley, VP and Head of Business Operations, Fortrea and joined by our below panelists.

Fortrea Innovation Theater
item0
Amy Hadley Discussion Leader | VP and Head of Business Operations, Fortrea
item1
Elizabeth Seyfert Panelist | Head of Site Engagement and Partnership Delivery, Fortrea
item2
Dana Glisson Panelist | Global Head Site Readiness & Regulatory Operations, Fortrea
item3
Jared Katz Panelist | Sr. Director, Development Cloud Strategy, Veeva Systems
item4
Stuart Cotter Panelist | VP of Product Strategy and Innovation, Advarra
item5
Brittany Weichers Panelist | Head of Global Patient Experience & Recruitment, Velocity
18 Jun | 9:15am - 9:45am

Responsibly Advancing the Use of Artificial Intelligence (AI) in Clinical Trials - Current Landscape, Common Misconceptions, and Future Opportunities

AI can help optimize operations, strengthen patient privacy, and improve data quality while reducing risks of human error in clinical trials. However, AI must be used responsibly and governed by the highest ethical principles with regard for data privacy and reducing bias in algorithm performance. Delve into the transformative role of AI in clinical trials: current industry status, common misconceptions, proactively tackling bias and navigating the evolving regulatory landscape.

Brian Dolan, VP, Artificial Intelligence & Machine Learning at Fortrea, is one of the panelists on this session, bringing his long history of practical AI/ML solution building to the discussion.

Exhibit Hall Theater #1
item0
Brian Dolan VP, Artificial Intelligence & Machine Learning at Fortrea
19 Jun | 1:15pm PDT

Regulatory Considerations in Trial Design for Cell and Gene Therapies

Paulla Dennis, Senior Director/Rare Diseases, Advanced Therapies, & Pediatrics at Fortrea, will be contributing to the session by speaking on Ethical, Clinical, and Timing Considerations for Administering Cell and Gene Therapies in Neonates and Early Childhood

Room 5AB
item0
Paulla Dennis Senior Director/Rare Diseases, Advanced Therapies, & Pediatrics at Fortrea